What is the current Price Target for the Connect Biopharma Holdings Ltd - ADR stock?

The average Connect Biopharma Holdings Ltd - ADR target price is $7.14. This is 312.72% higher than the current stock price. The highest price target is 355.20%, the lowest is 250.29%. 5 Analysts have issued a price target Connect Biopharma Holdings Ltd - ADR 2026 .

How high will the Connect Biopharma Holdings Ltd - ADR stock rise?

No reliable answer can be given as to how high the Connect Biopharma Holdings Ltd - ADR stock will rise. The performance of stocks, including the Connect Biopharma Holdings Ltd - ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Connect Biopharma Holdings Ltd - ADR stock today?

The performance of Connect Biopharma Holdings Ltd - ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Connect Biopharma Holdings Ltd - ADR stock fall?

The decline in Connect Biopharma Holdings Ltd - ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Connect Biopharma Holdings Ltd - ADR Forecast, price target & analysts

$1.73

3.59% yesterday

Nasdaq, Aug 21, 10:00 pm CET

ISIN

US2075231017

Symbol

CNTB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Connect Biopharma Holdings Ltd - ADR Target price 2025 - Analyst rating & recommendation

Connect Biopharma Holdings Ltd - ADR Classifications & Recommendation:

Buy

89%

Hold

11%

Connect Biopharma Holdings Ltd - ADR Price Target

Target Price	$7.14
Price	$1.73
Potential	312.72% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Connect Biopharma Holdings Ltd - ADR 2026 . The average Connect Biopharma Holdings Ltd - ADR target price is $7.14. This is 312.72% register free of charge higher than the current stock price. The highest price target is $7.88 355.20% register free of charge , the lowest is $6.06 250.29% register free of charge .
	A rating was issued by 9 analysts: 8 Analysts recommend Connect Biopharma Holdings Ltd - ADR to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Connect Biopharma Holdings Ltd - ADR stock has an average upside potential 2026 of 312.72% register free of charge . Most analysts recommend the Connect Biopharma Holdings Ltd - ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.28	-6.38
	75.22%	2,178.57%
P/E		negative

4 Analysts have issued a Connect Biopharma Holdings Ltd - ADR forecast for earnings per share. The average Connect Biopharma Holdings Ltd - ADR EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.28	75.22%
2025	$-6.38 2,178.57% Unlock
2026	$-4.93 22.73% Unlock
2027	$-3.97 19.47% Unlock
2028	$-0.62 84.38% Unlock
2029	$-0.32 48.39% Unlock
2030	$-0.18 43.75% Unlock
2031	$0.48 366.67% Unlock
2032	$0.94 95.83% Unlock

Current	-3.33	375.27%
2025	-0.27 91.88% Unlock
2026	-0.35 29.63% Unlock
2027	-0.44 25.71% Unlock
2028	-2.78 531.82% Unlock
2029	-5.47 96.76% Unlock
2030	-9.69 77.15% Unlock
2031	3.61 137.25% Unlock
2032	1.84 49.03% Unlock

Connect Biopharma Holdings Ltd - ADR...

Current Connect Biopharma Holdings Ltd - ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 13 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Apr 01 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 31 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 06 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 13 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Apr 01 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 31 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 06 2024

Discover more stocks with a high price target

Alibaba Group Holding Ltd 30.78%

Rheinmetall 28.98%

Coinbase Global, Inc. 27.38%

BioNTech SE - ADR 26.61%

Microsoft 26.43%

PayPal 24.57%

Deutsche Telekom 22.62%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now